Equillium Inc - יחס שווי כולל של החברה להכנסות EQ

Equillium, Inc. (EQ) utilizes California hubs for research while outsourcing antibody production to external CDMO facilities. The EV/Sales trend reflects the current market valuation, which has stabilized at 0.00. The development of inflammation immunotherapy relies on partnerships and the success of nephrological tests. Meanwhile, regular payments for the creation of itolizumab ensure financial stability as new pipeline projects mature.
פילוחי מדדים פיננסיים ומדדי שוק עבור Equillium, Inc. (EQ)

This indicator determines the total enterprise value of the business, accounting for net debt, and compares it to generated sales to identify asset overvaluation. By analyzing the EV/Sales trend, an investor assesses the capitalization efficiency of future revenues for Equillium, Inc. (EQ) derived from the commercialization of immunotherapeutic drugs designed to treat severe autoimmune pathologies of the kidneys and lungs.